Testing effectiveness (Phase 2)Active Not RecruitingNCT04006262
What this trial is testing
Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.
Who this might be right for
Localized Oesogastric AdenocarcimonaMSI and or dMMR
GERCOR - Multidisciplinary Oncology Cooperative Group 32